The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
European approval is based on robust Phase III data showing Cosentyx provided rapid symptom relief from as early as Week 4, with response rates continuing to improve up to 1 year1,3-5
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Subscribe To Our Newsletter & Stay Updated
